Delivery Order SPE2DB20D1109-SPE2DB24FP96D

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,064.30 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The delivery order has an ultimate completion date of August 2, 2024 and is a firm-fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The fixed-price, firm-fixed-price contract has a ceiling value of $1,082.06 and a period of performance through March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,545.80 and a period of performance through May 1, 2025. The contract is not set-aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The order is a firm-fixed-price contract with a ceiling value of $1,769.40 and an ultimate completion date of September 30, 2024. The award was made on September 27, 2024, and there is no set-aside designation. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,949.00 firm-fixed-price delivery order contract covers the supply of INFANRIX DTAP SYRINGE 0.5ML medical products. The contract has an ultimate completion date of August 21, 2024. While the original solicitation was not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP vaccine syringes. The contract has a ceiling value of $1,363.72 and a period of performance through January 28, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,769.40 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen holds a significant indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.22 firm fixed-price delivery order is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine product. The firm fixed price delivery order has a ceiling value of $2,824.94 and a period of performance through April 2, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that allows for the delivery of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,009.54 firm fixed-price delivery order is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine, with a completion date of January 21, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP96D
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The $2,949.00 fixed-price contract has a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:45 AM